Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

2021 Venture Investment Was Bullish – Will 2022 Be The Same?

Feb 21 2022

• By Barnaby Pickering

venture capital — • Source: Alamy

Related Content

Getting A Head Start: Medtech VC Aims Earlier Than Ever Before

Aug 19 2021

Finance Watch: IPOs At A Standstill As US Biotech Stock Valuations Plummet

Jan 28 2022

Neumora Launches With $500m To Advance Personalized Neuroscience Drugs

Oct 07 2021

Are SPACs Good Or Bad For Biopharma?

Feb 15 2021

Butterfly Network’s CEO Sees Blank Check Deal As Path To ‘Democratize’ Portable Imaging Platform

Dec 02 2020

CMR Surgical Closes SoftBank-Led Funding Round Worth $600M

Jun 28 2021

Investor Eye: Novalis Embraces Early Investment And Enabling Technology

Mar 30 2021

Hologic Continues Spending Spree With $230M Tuck-In Acquisition Of Biotheranostics

Jan 06 2021

Related Companies

EQRx, Inc.

Neumora Therapeutics, Inc.

Amgen, Inc.

Hologic, Inc.

Butterfly Network, Inc.

Tango Therapeutics, Inc.

Gilead Sciences, Inc.

Additional Topics

Growth Commercial Companies Deals Business Strategies BioPharmaceutical Medical Device

More from Growth

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window